92 related articles for article (PubMed ID: 20373899)
1. Chorioretinal ischemia and angiogenic milieu following photodynamic therapy.
Moon JW; Kim YJ; Khwarg SI; Chung H; Yu HG
Curr Eye Res; 2010 Apr; 35(4):314-21. PubMed ID: 20373899
[TBL] [Abstract][Full Text] [Related]
2. Factor VII-verteporfin for targeted photodynamic therapy in a rat model of choroidal neovascularization.
Lu F; Hu Z; Sinard J; Garen A; Adelman RA
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3890-6. PubMed ID: 19357351
[TBL] [Abstract][Full Text] [Related]
3. N-acetylcysteine protects against chorioretinal damage induced by photodynamic therapy for experimental choroidal neovascularization in a rat model.
Kim TW; Moon JW; Yu HG
Photodiagnosis Photodyn Ther; 2018 Sep; 23():12-17. PubMed ID: 29679669
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy induces caspase-dependent apoptosis in rat CNV model.
Matsubara A; Nakazawa T; Noda K; She H; Connolly E; Young TA; Ogura Y; Gragoudas ES; Miller JW
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4741-7. PubMed ID: 17898299
[TBL] [Abstract][Full Text] [Related]
5. Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.
Renno RZ; Terada Y; Haddadin MJ; Michaud NA; Gragoudas ES; Miller JW
Arch Ophthalmol; 2004 Jul; 122(7):1002-11. PubMed ID: 15249365
[TBL] [Abstract][Full Text] [Related]
6. Hypericin-mediated photodynamic therapy in combination with Avastin (bevacizumab) improves tumor response by downregulating angiogenic proteins.
Bhuvaneswari R; Yuen GY; Chee SK; Olivo M
Photochem Photobiol Sci; 2007 Dec; 6(12):1275-83. PubMed ID: 18046482
[TBL] [Abstract][Full Text] [Related]
7. [Expression of angiogenic factors by photodynamic therapy].
Rudolf M; Michels S; Schlötzer-Schrehardt U; Schmidt-Erfurth U
Klin Monbl Augenheilkd; 2004 Dec; 221(12):1026-32. PubMed ID: 15599809
[TBL] [Abstract][Full Text] [Related]
8. Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model.
Chen B; Pogue BW; Zhou X; O'Hara JA; Solban N; Demidenko E; Hoopes PJ; Hasan T
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):720-7. PubMed ID: 15701861
[TBL] [Abstract][Full Text] [Related]
9. Expression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapy.
Tatar O; Adam A; Shinoda K; Stalmans P; Eckardt C; Lüke M; Bartz-Schmidt KU; Grisanti S
Am J Ophthalmol; 2006 Jul; 142(1):95-104. PubMed ID: 16815256
[TBL] [Abstract][Full Text] [Related]
10. Effect of verteporfin photodynamic therapy on endostatin and angiogenesis in human choroidal neovascular membranes.
Tatar O; Shinoda K; Adam A; Eckert T; Eckardt C; Lucke K; Deuter C; Bartz-Schmidt KU; Grisanti S
Br J Ophthalmol; 2007 Feb; 91(2):166-73. PubMed ID: 16987895
[TBL] [Abstract][Full Text] [Related]
11. Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes.
Schlötzer-Schrehardt U; Viestenz A; Naumann GO; Laqua H; Michels S; Schmidt-Erfurth U
Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):748-57. PubMed ID: 12271373
[TBL] [Abstract][Full Text] [Related]
12. Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: angiographic and histologic characterization.
Zacks DN; Ezra E; Terada Y; Michaud N; Connolly E; Gragoudas ES; Miller JW
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2384-91. PubMed ID: 12091441
[TBL] [Abstract][Full Text] [Related]
13. Investigating the effect of ciliary body photodynamic therapy in a glaucoma mouse model.
Matsubara A; Nakazawa T; Husain D; Iliaki E; Connolly E; Michaud NA; Gragoudas ES; Miller JW
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2498-507. PubMed ID: 16723462
[TBL] [Abstract][Full Text] [Related]
14. The protective role of Visudyne eyeglass against VEGF synthesis after photodynamic therapy with verteporfin.
Türkçüoğlu P; Ilhan N; Kurt J; Aydemir O; Celiker U
Acta Ophthalmol; 2009 Nov; 87(8):871-4. PubMed ID: 19220205
[TBL] [Abstract][Full Text] [Related]
15. Reduced photoreceptor damage after photodynamic therapy through blockade of nitric oxide synthase in a model of choroidal neovascularization.
She H; Nakazawa T; Matsubara A; Hisatomi T; Young TA; Michaud N; Connolly E; Hafezi-Moghadam A; Gragoudas ES; Miller JW
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2268-77. PubMed ID: 17460290
[TBL] [Abstract][Full Text] [Related]
16. Vascular regrowth following photodynamic therapy in the chicken embryo chorioallantoic membrane.
Nowak-Sliwinska P; van Beijnum JR; van Berkel M; van den Bergh H; Griffioen AW
Angiogenesis; 2010 Dec; 13(4):281-92. PubMed ID: 20842454
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression.
Ozaki H; Yu AY; Della N; Ozaki K; Luna JD; Yamada H; Hackett SF; Okamoto N; Zack DJ; Semenza GL; Campochiaro PA
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):182-9. PubMed ID: 9888442
[TBL] [Abstract][Full Text] [Related]
18. Consequences of verteporfin photodynamic therapy on choroidal neovascular membranes.
Tatar O; Kaiserling E; Adam A; Gelisken F; Shinoda K; Völker M; Lafaut BA; Bartz-Schmidt KU; Grisanti S
Arch Ophthalmol; 2006 Jun; 124(6):815-23. PubMed ID: 16769835
[TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma.
Ferrario A; von Tiehl KF; Rucker N; Schwarz MA; Gill PS; Gomer CJ
Cancer Res; 2000 Aug; 60(15):4066-9. PubMed ID: 10945611
[TBL] [Abstract][Full Text] [Related]
20. Neurotrophic factors minimize the retinal toxicity of verteporfin photodynamic therapy.
Paskowitz DM; Donohue-Rolfe KM; Yang H; Yasumura D; Matthes MT; Hosseini K; Graybeal CM; Nune G; Zarbin MA; Lavail MM; Duncan JL
Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):430-7. PubMed ID: 17197564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
